|
Re: treatments
Nguyen
You did excelletly. its hard to believe you have no training because you know this wll and are a good source of information. As far as mistakes go I dont see any except one possible one. For some reason as far as I know, the CDK 46 inhibitors are not approved for Her 2 Neu positive cancers. please correct me if Im wrong.
I was interested in what you said about Raloxifine (Evista). It works very much like Tamoxifen except for one very positive ting. There is little or no risk of uterine cancer with Evista as it has no proestrogenic effects on the uterus wheas Tamoxifen has. Despite this as far as I know the FDA approval for Evista is only for Osteoporosis and the insurance companies hide behind FDA approval. If the approval for Raloxifene includes breast cancer Id love to know about this. It makes sense. Ive been retired for 9 years now and dont keep us as well as I should.
Paul
Please forgive any mispellings
|
Hybrid Mode
